You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach
|
---|---|
Published in |
Breast Cancer Research, June 2012
|
DOI | 10.1186/bcr3208 |
Pubmed ID | |
Authors |
Tim JA Dekker, Susan Ter Borg, Gerrit KJ Hooijer, Sybren Lf Meijer, Jelle Wesseling, James E Boers, Ed Schuuring, Jos Bart, Joost van Gorp, Wilma E Mesker, Judith R Kroep, Vincent THBM Smit, Marc J van de Vijver |
Abstract |
Overexpression of the human epidermal growth factor receptor 2 (HER2) as a result of HER2 gene amplification is associated with a relatively poor prognosis in breast cancer and is predictive of HER2-targeting therapy response. False-positive rates of up to 20% for HER2 testing have been described. HER2-testing laboratories are therefore encouraged to participate in external quality control schemes in order to improve HER2-testing standardization. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 2 | 4% |
United Kingdom | 1 | 2% |
Chile | 1 | 2% |
Germany | 1 | 2% |
Unknown | 51 | 91% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 11 | 20% |
Student > Bachelor | 7 | 13% |
Student > Master | 6 | 11% |
Other | 4 | 7% |
Student > Ph. D. Student | 4 | 7% |
Other | 11 | 20% |
Unknown | 13 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 22 | 39% |
Agricultural and Biological Sciences | 8 | 14% |
Biochemistry, Genetics and Molecular Biology | 5 | 9% |
Immunology and Microbiology | 2 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Other | 4 | 7% |
Unknown | 14 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 April 2017.
All research outputs
#3,274,399
of 25,373,627 outputs
Outputs from Breast Cancer Research
#347
of 2,052 outputs
Outputs of similar age
#21,157
of 181,067 outputs
Outputs of similar age from Breast Cancer Research
#3
of 43 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,052 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 181,067 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.